Evolution of cocoa flavanol analytics: impact on reporting and cross-study comparison
Ugo Bussy1, Javier I Ottaviani2, Catherine Kwik-Uribe1
1Mars Incorporated, 6885 Elm St, McLean, VA 22101, USA. ugo.bussy@effem.com.
Abstract:
Cocoa flavanols (CF) are a group of dietary bioactives that have been studied for their potential health benefits for over two decades. In this time, multiple methods for CF testing have evolved, introducing the potential for differences in reported CF content. The reliable characterization of CF content in food and test materials used in clinical studies is critical to comparisons of research studies over time, as well as critical to enabling the systematic reviews and meta-analyses required to support dietary recommendations of bioactives. In this work, we compared two analytical methods that have been widely applied to characterize materials used in clinical research and a method newly recognized by AOAC as the official method for CF analysis. Differences in accuracy of -36% to +20% were observed when comparing CF contents determined with these methods, supporting the notion that CF values determined across methods are not directly comparable. To address differences, a linear regression model was developed to predict CF values. This approach was cross-validated and directly applied to the conversion of CF values published in key scientific papers on the benefits of CF. This work provides a valid tool to compare CF values reported across these different methods and enables comparisons and interpretation of studies investigating the bioactivity of CF.
More Related Videos
07:12Protocol for Data Collection and Analysis Applied to Automated Facial Expression Analysis Technology and Temporal Analysis for Sensory Evaluation
Published on: August 26, 2016
05:52Author Spotlight: Tissue Culture-Free Agrobacterium-Mediated Transformation in Large Woody Plants
Published on: November 17, 2023
Related Concept Videos
Drug Product Performance: In Vitro–In Vivo Correlation
Bioequivalence Data: Statistical Interpretation
Therapeutic Drug Monitoring: Drug Analysis Methods
Bioavailability: Influencing Factors
Bioavailability Study Design: Absolute Versus Relative Bioavailability
Bioavailability Study Design: Single Versus Multiple Dose Studies
